GW Pharma (GWP) - GW Pharma continues to drift downwards following the positive news on Sativex a couple of weeks ago. Things are expected to be quiet until May onwards when an update on national approval from the UK and Spanish regulatory authorities would be expected. The interims are also in May and news on other regional licensing deals outside North America and Europe would be expected as well as the U.S. FDA cancer pain application wit Otsuka Corp.. I sold around 2/3 of my holding on the news and bought back some at 115p. I am monitoring this share closely for a further buying opportunities on a slide back below 110p because May and June news should drive this to well over 130p.
Norseman Gold (NGL) - A position was started in this Australian gold company on Monday. See the previous article, http://contrarianinvestoruk.blogspot.com/2010/03/norseman-gold-looks-solid-australian.html.
Coal of Africa (CZA) - The Coal of Africa position was increased this week as Morgan Stanley increased their share target to 200p (current 145p) and a full UK market listing is due.
BHP Billiton (BLT) - A contrarian short on BHP Billiton was placed on Thursday morning following a week of strong rises as the rise in commodity stocks seems overcooked.
Genzyme (GENZ) - The position was closed on the rebound to $53.
Micron (MU) - Short term trades at just over $10.2 were made and closed before the quarterly earnings at $10.8
No comments:
Post a Comment